A Pharmaceutical Company Helps Epileptic Patients ‘Speak’ via Music and Paintings


[Editor’s Note:Companies sometimes struggle to connect CSR with their corporate values. The story below illustrates an innovative way a pharmaceutical translated its interest in offering patients creative solutions into a CSR effort.

In 2019, cannabinoid pharmaceuticals company Greenwich Biosciences, the U.S. arm of GW Pharmaceuticals plc of the U.K., embarked on a program to enhance the lives of epilepsy patients, the customers of its medicines. In addition to suffering seizures, some epilepsy patients are unable to speak. It makes getting to know them difficult.

One way such patients express themselves is through visual art. Now, patients’ art can be uploaded to GW Pharma’s unspoken symphony site, where an image-recognition program ‘reads’ the art. It’s then translated into music.


Access to all Crisis Insider articles, quarterly reports and valuable blueprints for crisis management.


Per Month Lowest Price


Best Value!

Unlimited access to all Premium and Crisis Insider articles and monthly reports.

First Year Offer


Per Month


Unlimited access to all Premium digital intelligence, 10-year web archive and monthly reports.

Save $140 With Annual Subscription


Per Month